Case name: Endo International
Settlement fund: $50,000,000
Claim filing deadline:11/14/2019
Class period: 6/5/2015 – 11/13/2018 (Purchase period: 6/5/2015 - 6/10/2015)
Definition of class from settlement notice: “If you purchased or otherwise acquired the publicly traded common stock of Endo International issued in or traceable to the Company’s June 5, 2015 secondary offering of common stock, you may be entitled to a payment from a class action settlement.”
Eligible securities in brief: Common stock purchased or acquired pursuant to secondary public offering between June 5, 2015 and June 10, 2015
Fairness Hearing: 10/21/2019
Exclusion Deadline: 9/30/2019
Objection Deadline: 9/30/2019
What this case is about: Plaintiffs alleged that the Offering Documents failed to disclose declining demand for Endo’s generic products, and that personnel in its generic division had resorted to unsustainable business practices to meet sales numbers. When Defendants allegedly revealed the existence of these negative trends and the impact they had on Endo’s finances, the Company’s stock price fell well below the Offering price. Plaintiffs also alleged that Endo International conspired to fix prices for generic drugs with Par Pharamceuticals, which Endo acquired during 2015. Endo faced both a criminal investigation by the department of justice and an antitrust suit brough by 47 State Attorneys General.
According to the complain, "Defendants’ statements concealed that a material portion of Endo’s profits resulted from extraordinary price increases, after which Defendants did not compete with their historic cutthroat rivals. Shareholders did not know that, contrary to Defendants’ false statements, Endo was in fact not competing, and the touted profits were highly at risk of vanishing if competition resumed. As would come to pass, once Endo was the subject of a law enforcement subpoena in December 2015, Defendants’ ability to sustain the scheme, let alone make more anticompetitive price increases, ceased; the once steady flow of Inflated Profits began to evaporate."
How Chicago Clearing Can Help: Every day, our team files claims in financial class action litigations. We are preparing claims now for potential Endo International Class members. If you or your clients are eligible for this litigation, or any of the other 32 settlements with upcoming deadlines, then pease give us a call at 312-204-6970.
Good news for those investors who purchased Valeant securities between February 28, 2014 and October 21, 2015. Plaintiffs and Valeant (now known as Bausch Health) have hammered out a $1.21 billion settlement. Settlement notices and claim forms are not yet available, but Chicago Clearing Corporation (CCC) will begin preparing claims f... Read More
Did you trade debt securities of government sponsored enterprises (aka GSE bonds) between 2009 and 2019? If so, you may be eligible to participate in an antitrust settlement.
Plaintiffs allege that the defendants (see full list below) conspired to fix prices of unsecured GSE bonds issued by Federal ... Read More
Case Name: Akorn 2019 Securities Settlement
Settlement Fund: Between $53.6 million and $155.4 Million
Claim Filing Deadline: January 24, 2020
Class Period: 11/3/2016 – 1/8/2019
Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”
So what’s the difference? Aside from $32.5 million.
The first settlement pertained to declining demand for Endo’s generic drugs and also alleged th... Read More
Investors in American Realty Capital Properties (ARCP), now known as Vereit, may be eligible for a massive settlement that could pay as much as 50% of damages. Given that the typical recovery is just 2%, this is great news for harmed ARCP investors.
What is this case about?
ARCP was an investment services firm fou... Read More
“I could go on and on, but bottom line, the fees being charged are much less than what I was spending in house to file and this is just one less thing I have to spend time trying to figure out how to complete on a consistent basis. I send the data on an annual basis to CCC and they take it from there. My clients are protected (if there is a class action, it is getting filed), the Bank is protected (we are meeting our fiduciary obligation by filing the claims) and…dealing with the CCC staff has been a very positive thing.”
John E. Thomason, The National Bank of Indianapolis
“We were spending countless hours on class action claims before we signed on with CCC in January. Matt Murray and their technical team ensured our data transmission was seamless and secure. We found everyone at CCC to be professional, courteous, and accommodating.”
Carie A. Minnie, Torrington Savings Bank
“We found filing securities claims very time consuming and laborious. But after signing with CCC, it’s been great! Everything is handled behind the scenes.”
Carol A. Neville, Proffitt & Goodson
“Signing with CCC has made a huge difference. Before, it was horrible. We had to print thousands of pieces of paper, invite clients to come in and sit down with us to show them where to find the transactions, how to input them into the Proof of Claim forms…Now, we do some minor leg work up front when a new account is opened, and then upload our spreadsheet to CCC. And then, voila! It’s very nice to be able to tell our client, “You can shred that Proof of Claim form because CCC has it taken care of.”
Daniela Jones, Barnes Investment Advisory
“Your client reporting portal and customer service is the reason we chose Chicago Clearing.”
Debbie Kirby, Bank of the Ozarks